通过Smad3介导的NLRP3炎症酶激活,C-反应蛋白促进糖尿病病
Yifan Wang1, Yong-Ke You2, Jianbo Guo1
1School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Molecular therapy : the journal of the American Society of Gene Therapy
|November 14, 2024
概括
C-反应蛋白 (CRP) 通过激活Smad3-NLRP3炎症体通路,导致脏炎症,使糖尿病病 (DKD) 恶化. 准CRP或这种途径为DKD提供了潜在的新疗法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 糖尿病病 (DKD) 是末期病的主要原因之一.
- 众所周知,C-反应蛋白 (CRP) 通过炎和纤维化使DKD恶化.
- NLRP3炎症酶是炎的关键调解者,但其在CRP诱导的DKD中的作用尚不清楚.
研究的目的:
- 研究CRP是否通过NLRP3炎症酶通路加剧DKD炎症.
- 阐明CRP如何影响DKD中的Smad3和NLRP3炎症酶激活的机制.
主要方法:
- 利用过度表达人类CRP的小鼠,并将它们置于糖尿病条件下.
- 在体外研究中使用中和抗CD32抗体来阻止CRP信号传递.
- 研究了基因删除和Smad3的药理抑制对NLRP3激活的影响.
- 进行了分子分析,以确定Smad3与NLRP3基因促进物结合.
主要成果:
- 过度表达CRP的小鼠在糖尿病脏中表现出加速的脏炎症,与Smad3和NLRP3炎症酶激活有关.
- 在体外阻断CRP信号减少了Smad3和NLRP3的激活.
- 在糖尿病脏和高葡萄糖治疗细胞中,Smad3的删除或抑制减轻了CRP诱导的NLRP3激活.
- CRP增强了Smad3与NLRP3基因促进体的结合.
结论:
- 在DKD中,CRP通过一种依赖于Smad3介导的NLRP3炎症酶激活的机制促进炎.
- 准CRP或Smad3-NLRP3通路为DKD提供了一个潜在的治疗策略.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
500
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
99
相关概念视频
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...